Citigroup
ACUR

Citigroup’s Acura Pharmaceuticals ACUR Stock Holding History

Citigroup’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-56
Closed – – 8045
2015
Q4 		$0 Buy
+56
New +$136 ﹤0.01% 8117
2015
Q2 		– Sell
-62
Closed – – 7967
2015
Q1 		$0 Buy
+62
New +$198 ﹤0.01% 7633
2014
Q2 		– Sell
-427
Closed -$3K – 7479
2014
Q1 		$3K Sell
427
-18
-4% -$156 ﹤0.01% 6743
2013
Q4 		$4K Sell
445
-547
-55% -$4.62K ﹤0.01% 6685
2013
Q3 		$9K Buy
992
+986
+16,433% +$8.72K ﹤0.01% 6264
2013
Q2 		$0 Buy
+6
New +$68 ﹤0.01% 6850

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Citigroup's ACUR Position: Q1 2016 in Review

Citigroup sold out of Acura Pharmaceuticals (ACUR) in Q1 2016, closing a stake of 56 shares.

Citigroup first reported a position in ACUR in Q2 2013 and held it in 6 quarters. The position peaked at $9K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q1 2016.

  • Citigroup reported no remaining Acura Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 56 Acura Pharmaceuticals shares in Q1 2016.
  • Citigroup first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Citigroup's Acura Pharmaceuticals position peaked at $9K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.